144 related articles for article (PubMed ID: 35361004)
1. Early screening outcomes among non-immigrants and immigrants targeted by BreastScreen Norway, 2010-2019.
Thy JE; Bhargava S; Larsen M; Akslen LA; Hofvind S
Scand J Public Health; 2023 May; 51(3):403-411. PubMed ID: 35361004
[TBL] [Abstract][Full Text] [Related]
2. Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme.
Bhargava S; Akslen LA; Bukholm IRK; Hofvind S
Eur Radiol; 2019 Sep; 29(9):4833-4842. PubMed ID: 30762109
[TBL] [Abstract][Full Text] [Related]
3. Participation and cancer detection after reminders versus ordinary invitations in BreastScreen Norway.
Thy JE; Vigeland E; Larsen M; Hofvind S
J Med Screen; 2022 Sep; 29(3):178-184. PubMed ID: 35502849
[TBL] [Abstract][Full Text] [Related]
4. Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.
Hovda T; Brandal SHB; Sebuødegård S; Holen ÅS; Bjørndal H; Skaane P; Hofvind S
Eur Radiol; 2019 Dec; 29(12):6991-6999. PubMed ID: 31187221
[TBL] [Abstract][Full Text] [Related]
5. Lower attendance rates in immigrant versus non-immigrant women in the Norwegian Breast Cancer Screening Programme.
Bhargava S; Tsuruda K; Moen K; Bukholm I; Hofvind S
J Med Screen; 2018 Sep; 25(3):155-161. PubMed ID: 29059006
[TBL] [Abstract][Full Text] [Related]
6. Early performance measures following regular versus irregular screening attendance in the population-based screening program for breast cancer in Norway.
Thy JE; Larsen M; Vigeland E; Koch H; Hovda T; Hofvind S
J Med Screen; 2024 Jun; 31(2):107-114. PubMed ID: 37691575
[TBL] [Abstract][Full Text] [Related]
7. Lower participation among immigrants in colorectal cancer screening in Norway.
Bhargava S; Botteri E; Berthelsen M; Iqbal N; Randel KR; Holme Ø; Berstad P
Front Public Health; 2023; 11():1254905. PubMed ID: 37822535
[TBL] [Abstract][Full Text] [Related]
8. Attendance in BreastScreen Norway among immigrant and Norwegian-born women.
Bhargava S; Mangerud G; Hofvind S
Tidsskr Nor Laegeforen; 2021 Feb; 141(2):. PubMed ID: 33528126
[TBL] [Abstract][Full Text] [Related]
9. Effect of invitation letter in language of origin on screening attendance: randomised controlled trial in BreastScreen Norway.
Hofvind S; Iqbal N; Thy JE; Mangerud G; Bhargava S; Zackrisson S; Berstad P
BMJ; 2023 Sep; 382():e075465. PubMed ID: 37726122
[TBL] [Abstract][Full Text] [Related]
10. Self-reported symptoms among participants in a population-based screening program.
Larsen M; Lilleborge M; Vigeland E; Hofvind S
Breast; 2020 Dec; 54():56-61. PubMed ID: 32927237
[TBL] [Abstract][Full Text] [Related]
11. Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study.
Tsuruda KM; Hoff SR; Akslen LA; Hofvind S
Br J Cancer; 2024 Jan; 130(1):99-107. PubMed ID: 38049556
[TBL] [Abstract][Full Text] [Related]
12. Differences in mammography screening attendance among non-Western immigrants in Denmark, Finland, Iceland and Norway.
Njor SH; Heinävaara S; Stefansdóttir H; Nygård M; Guðmundsdóttir EM; Bhargava S; Leivonen A; Campbell S; Søborg B; Hofvind S; Sarkeala T; Vejborg I; Lamminmäki M
Prev Med Rep; 2023 Dec; 36():102516. PubMed ID: 38116274
[TBL] [Abstract][Full Text] [Related]
13. Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996-2020.
Moshina N; Backmann HA; Skaane P; Hofvind S
Eur Radiol; 2024 May; 34(5):3364-3374. PubMed ID: 37935848
[TBL] [Abstract][Full Text] [Related]
14. Screening at stationary versus mobile units in BreastScreen Norway.
Holen Å; Sebuødegård S; Waade GG; Aase H; Hopland NM; Pedersen K; Larsen M; Tsuruda KM; Hofvind S
J Med Screen; 2020 Mar; 27(1):31-39. PubMed ID: 31554445
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with attendance and attendance patterns in a population-based mammographic screening program.
Larsen M; Moshina N; Sagstad S; Hofvind S
J Med Screen; 2021 Jun; 28(2):169-176. PubMed ID: 34053363
[TBL] [Abstract][Full Text] [Related]
16. Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway.
Tsuruda KM; Larsen M; Román M; Hofvind S
Cancer; 2022 Apr; 128(7):1373-1380. PubMed ID: 34931707
[TBL] [Abstract][Full Text] [Related]
17. Risk of breast cancer by prior screening results among women participating in BreastScreen Norway.
Lilleborge M; Falk RS; Russnes H; Sauer T; Ursin G; Hofvind S
Cancer; 2019 Oct; 125(19):3330-3337. PubMed ID: 31206638
[TBL] [Abstract][Full Text] [Related]
18. Interval and Consecutive Round Breast Cancer after Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Standard 2D Digital Mammography in BreastScreen Norway.
Hovda T; Holen ÅS; Lång K; Albertsen JL; Bjørndal H; Brandal SHB; Sahlberg KK; Skaane P; Suhrke P; Hofvind S
Radiology; 2020 Feb; 294(2):256-264. PubMed ID: 31821118
[TBL] [Abstract][Full Text] [Related]
19. Differences in cervical cancer screening between immigrants and nonimmigrants in Norway: a primary healthcare register-based study.
Møen KA; Kumar B; Qureshi S; Diaz E
Eur J Cancer Prev; 2017 Nov; 26(6):521-527. PubMed ID: 27749381
[TBL] [Abstract][Full Text] [Related]
20. Understanding the participation of breast screening among women born in predominantly Muslim countries living in Victoria, Australia from record-linkage data.
Yeasmeen T; Kelaher M; Brotherton JML; Malloy MJ
PLoS One; 2020; 15(8):e0237341. PubMed ID: 32764828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
